1. Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells
   Yao-Hua Liu et al, 2019, Cancers CrossRef
2. Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines
   Rita Ahmed et al, 2020, Current Opinion in Biotechnology CrossRef
3. PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit anIn VitroAntileukemic Immune Response
   Sara Trabanelli et al, 2015, Journal of Immunology Research CrossRef
4. The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
   Rikito Endo et al, 2019, Scientific Reports CrossRef
5. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases
   Fahimeh Heidari et al, 2022, International Reviews of Immunology CrossRef
6. RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?
   Zhongji Meng et al, 2017, Frontiers in Immunology CrossRef
7. Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells
   Ke He et al, 2016, Bioscience Reports CrossRef
8. Gene-modified dendritic cell vaccines for cancer
   Rebecca S. Abraham et al, 2016, Cytotherapy CrossRef
9. Comparative assessment of lipid based nano-carrier systems for dendritic cell based targeting of tumor re-initiating cells in gynecological cancers
   Arpit Bhargava et al, 2016, Molecular Immunology CrossRef
10. Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
    Annelisa M. Cornel et al, 2018, Frontiers in Immunology CrossRef
11. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies
    Domenico Galati et al, 2018, Cytotherapy CrossRef
12. Nucleic acid-based immune checkpoint blockade: Progress and potential
    Adam A. Walters et al, 2022, Systemic Drug Delivery Strategies CrossRef
13. A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
    Dong-Sup Chung et al, 2014, Journal of Immunology Research CrossRef
14. Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference
    Stein Sæbøe-Larssen et al, 2020, RNA Interference and CRISPR Technologies CrossRef
15. Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer
    Mariela A. Moreno Ayala et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
16. Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
    Mouldy Sioud, 2019, Cancers CrossRef
17. Engineering better immunotherapies via RNA interference
    Mouldy Sioud, 2014, Human Vaccines & Immunotherapeutics CrossRef
18. From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
    Mahdi Abdoli Shadbad et al, 2021, Frontiers in Immunology CrossRef
19. Dendritic cell transfer for cancer immunotherapy
    Liwei Zhao et al, 2022, Adoptive Cell Transfer CrossRef
20. Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
    Mouldy Sioud, 2020, RNA Interference and CRISPR Technologies CrossRef
21. Gene Therapy and Genetic Vaccines
    Sara Hemmati et al, 2021, Cancer Immunology CrossRef
22. The MRI-Visible Nanocomposite Facilitates the Delivery and Tracking of siRNA Loaded DC Vaccine in the Breast Cancer Model
    Changqiang Wu et al, 2021, Frontiers in Oncology CrossRef
23. Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy
    Udo S Gaipl et al, 2014, Immunotherapy CrossRef
24. Overcoming the Challenges of siRNA Activation of Innate Immunity: Design Better Therapeutic siRNAs
    Mouldy Sioud, 2015, RNA Interference CrossRef
25. Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
    Mouldy Sioud et al, 2016, Case Reports in Medicine CrossRef
26. Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready ‘N Able to Improve Clinical Outcome?
    Yannick Willemen et al, 2020, Cancers CrossRef
27. Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours - A prognostic test after surgical resection
    Matthias Kolberg et al, 2015, Molecular Oncology CrossRef
28. Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved Immunotherapy
    Hao Qin et al, 2021, Advanced Materials CrossRef
29. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer
    Gang Wang et al, 2019, Current Cancer Drug Targets CrossRef
30. Immunosuppressive Factor Blockade in Dendritic Cells via siRNAs Results in Objective Clinical Responses
    Mouldy Sioud et al, 2015, RNA Interference CrossRef